Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.6 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |